Introduction
- Drug-eluting stents have become the gold standard in PCI procedures; it is
up for debate as to whether biodegradable stents become the future gold
standard. The debate about PCI vs thrombolysis still continues, however
opinion seems to be falling firmly on the side of PCI.
Scope of this report
- Market overview and review of the rise of drug eluting stents to
gold-standard status, with an update on clinical trials and reimbursement
status
- Identify the key players in the PCI drug-eluting stent market and
understand how this is likely to change with the advent of biodegradable
stents
- Follow the debate on PCI vs. thrombolysis and understand why opinion
leaders seem to favor PCI
- Understand the critical issue around time-to-needle and remote transfer
Research and analysis highlights
- The drug-eluting stent seems to be the device for the future by solving
(and promising to solve) one of the largest problems of interventional
coronary treatment: restenosis. Opinion leaders interviewed by Datamonitor
in 2004 suggest that the use of drug-eluting stents has reached 9095% of the
stent market both in the US and Europe.
- It is now thought that even with the additional delay, transfer of
patients for PCI is associated with better outcomes than treating with
thrombolysis at the local hospital.
- When primary PCI cannot be provided readily and transfer is necessary,
intravenous thrombolysis may be a better choice for patients seen early
(within the first two hours), especially if it can be provided in a
pre-hospital setting. This does not preclude subsequent transfer to an
interventional center.
Key reasons to read this report
- Understand the reasons for the success of drug-eluting stents and their
rise to becoming the gold-standard treatment
- Identify the key players in the PCI drug-eluting stent market and
understand how the market will evolve with the advent of biodegradable
stents
- Understand why opinion leaders seem to favor PCI over thrombolysis and the
critical issue around time-to-needle and remote transfer
View Cart
